Our Product and Marketing Manager, Dr Zoe Nilsson, presented on The Future of Cell Line Development at BioProcess International Asia conference in Tokyo, Japan in February. 

Download the presentation to find out more on how the microfluidic-based picodroplet technology of Cyto-Mine^® addresses the major challenges in cell line development. 

This presentation highlights how Cyto-Mine^®  provides a solution to resource-intensive, time-consuming and expensive workflows by streamlining cell isolation, titre determination and clonality assurance while reducing costs for biopharmaceutical discovery and development.